Siqi Pang , Zhulin Qiao , Jiajia Xu , Hao Tang , Qiuhong Zhang , Weiyao Han , Lu Peng , Jiaojiao Yang , Jiao Zhang , Qi Huang , Rui Zhou , Lu Li
{"title":"Streptococcus suis AdcA interacts with factor H and inhibits C3b deposition on the bacteria to participate in complement evasion","authors":"Siqi Pang , Zhulin Qiao , Jiajia Xu , Hao Tang , Qiuhong Zhang , Weiyao Han , Lu Peng , Jiaojiao Yang , Jiao Zhang , Qi Huang , Rui Zhou , Lu Li","doi":"10.1016/j.vetmic.2025.110561","DOIUrl":null,"url":null,"abstract":"<div><div><em>Streptococcus suis</em> is an important zoonotic pathogen. It can escape from the host complement attack through various strategies. In this study, the possible complement C3b interacted proteins of <em>S. suis</em> were screened by co-immunoprecipitation (Co-IP) using C3b antibody in human serum. A bacterial Zn<sup>2+</sup> transporter AdcA detected to be a cell wall protein was identified. The interaction of AdcA with C3b was verified in the same Co-IP setup using AdcA antibody by western-blot, but after far-western blot analysis, AdcA was found to not interact with C3b directly, but interacted directly with factor H (FH), the complement regulatory factor inhibiting the cleavage of C3 and the production of C3b. Thereafter, the interaction sites of AdcA and FH were predicted using molecular docking. Then, an <em>adcA</em> gene deletion mutant Δ<em>adcA</em>, a complementary strain CΔ<em>adcA</em> and point mutant strains containing AdcA-FH interaction sites Δ<em>adcA</em><sub><em>FH(P-G)</em></sub> (N-terminal) and Δ<em>adcA</em><sub><em>FH(Y-P)</em></sub> (C-terminus) were constructed. The deposition of C3b on the surface of Δ<em>adcA</em>, Δ<em>adcA</em><sub><em>FH(P-G)</em></sub> and Δ<em>adcA</em><sub><em>FH(Y-P)</em></sub> was significantly increased compared to the wild-type (WT) or CΔ<em>adcA</em>. The resistance to opsonophagocytosis and survival rates in serum of Δ<em>adcA</em> and Δ<em>adcA</em><sub><em>FH(P-G)</em></sub> were significantly reduced compared to WT or CΔ<em>adcA</em>. Additionally, deletion of <em>adcA</em> decreased bacterial loads of <em>S. suis</em> in the blood, brain and lung of mice. Taken together, AdcA inhibited C3b deposition on the surface of <em>S. suis</em> by binding to FH, further inhibiting the C3b-mediated opsonophagocytosis and serum survivability of <em>S. suis</em>. Both the complement evasion and the known Zn<sup>2+</sup> transport roles of AdcA contributed to pathogenicity of <em>S.suis</em>.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"306 ","pages":"Article 110561"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525001968","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Streptococcus suis is an important zoonotic pathogen. It can escape from the host complement attack through various strategies. In this study, the possible complement C3b interacted proteins of S. suis were screened by co-immunoprecipitation (Co-IP) using C3b antibody in human serum. A bacterial Zn2+ transporter AdcA detected to be a cell wall protein was identified. The interaction of AdcA with C3b was verified in the same Co-IP setup using AdcA antibody by western-blot, but after far-western blot analysis, AdcA was found to not interact with C3b directly, but interacted directly with factor H (FH), the complement regulatory factor inhibiting the cleavage of C3 and the production of C3b. Thereafter, the interaction sites of AdcA and FH were predicted using molecular docking. Then, an adcA gene deletion mutant ΔadcA, a complementary strain CΔadcA and point mutant strains containing AdcA-FH interaction sites ΔadcAFH(P-G) (N-terminal) and ΔadcAFH(Y-P) (C-terminus) were constructed. The deposition of C3b on the surface of ΔadcA, ΔadcAFH(P-G) and ΔadcAFH(Y-P) was significantly increased compared to the wild-type (WT) or CΔadcA. The resistance to opsonophagocytosis and survival rates in serum of ΔadcA and ΔadcAFH(P-G) were significantly reduced compared to WT or CΔadcA. Additionally, deletion of adcA decreased bacterial loads of S. suis in the blood, brain and lung of mice. Taken together, AdcA inhibited C3b deposition on the surface of S. suis by binding to FH, further inhibiting the C3b-mediated opsonophagocytosis and serum survivability of S. suis. Both the complement evasion and the known Zn2+ transport roles of AdcA contributed to pathogenicity of S.suis.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.